AGM
- NYSE - FINANCIAL SERVICES - Credit Services
Federal Agric Mtg Cl C
|
$27.08 |
-0.28
-1.02%
|
$27.54
|
$27.73
|
-2.34% |
40,666
79.27%
|
51,300
|
Most Recent Note for AGM - 7/9/2012 11:56:34 AM
Consolidating -1.8% off its 52-week high today, above support at its 50 DMA line and prior highs in the $23 area. Reported earnings +27% on +10% sales revenues for the quarter ended March 31, 2012 versus the year ago period. Last noted in the 5/31/12 mid-day report - "Quarterly earnings increases have been strong in recent comparisons through Dec '11, however its underlying sales revenues and its annual earnings (A criteria) growth history are not meeting the fact-based investment system's guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CSL
- NYSE - Diversified Operations
Carlisle Cos Inc
|
$53.29 |
-1.00
-1.84%
|
$53.85
|
$56.67
|
-5.96% |
444,345
117.58%
|
377,900
|
Most Recent Note for CSL - 7/9/2012 11:59:00 AM
Consolidating without making any further progress since last noted in the 5/01/12 mid-day report following a considerable gap up gain on 4/24/12 for new 52-week and all-time highs, clear of all overhead supply. Reported strong sales revenues and earnings increases in the Mar '12 quarterly comparison versus the year ago period. Fundamentals have improved while it went through a deep consolidation below its 200 DMA line since noted in the 7/19/11 mid-day report when it was encountering stubborn resistance near its then all-time high ($51.57 in 2007) - "Recent quarters showed improved sales and earnings but prior history has been below guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CVS
- NYSE - RETAIL - Drug Stores
C V S Caremark Corp
|
$47.29 |
-0.83
-1.72%
|
$48.00
|
$48.31
|
-2.11% |
4,498,870
59.46%
|
7,565,900
|
Most Recent Note for CVS - 7/9/2012 12:02:26 PM
Pulling back from new 52-week and all-time highs today after recently wedging to new high territory without great volume conviction behind a streak of 8 consecutive small gains. Last noted in the 5/18/12 mid-day report - "Fundamental (earnings growth) concerns still apply through its Mar '12 quarterly results after the Retail - Drug Store firm reported earnings +14% on +20% sales revenues versus the year ago period. It survived but failed to impress since long ago noted in the 5/06/08 mid-day report - 'Earnings growth below guidelines.'"
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
EFC
- NYSE - BANKING - Savings & Loans
Ellington Financial
|
$21.75 |
+0.05
0.25%
|
$21.85
|
$21.91
|
-0.71% |
33,957
69.73%
|
48,700
|
Most Recent Note for EFC - 7/9/2012 12:04:11 PM
Still consolidating above its 50 DMA line. Noted in prior mid-day reports - "Reported earnings +3% on -1% sales revenues for the quarter ended March 31, 2012 versus the year ago period following stronger increases in prior comparisons."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
FHCO
- NASDAQ - CONSUMER NON-DURABLES - Personal Products
Female Health Co
|
$6.46 |
+0.07
1.10%
|
$6.49
|
$6.62
|
-2.42% |
86,158
131.94%
|
65,300
|
Most Recent Note for FHCO - 7/9/2012 12:07:49 PM
Hitting new 52-week highs today with above average volume behind a spurt of gains. It survived but failed to impress since last noted in the 8/26/09 mid-day report -"Recent quarters showed big earnings improvements over the year ago period. However, sales revenues increases have been erratic, below guidelines, and rather minuscule (at $5-7 million or so per quarter)."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GABC
- NASDAQ - BANKING - Regional - Midwest Banks
German American Bancorp
|
$20.33 |
-0.15
-0.73%
|
$20.58
|
$21.98
|
-7.51% |
16,336
70.72%
|
23,100
|
Most Recent Note for GABC - 7/9/2012 12:10:01 PM
Reported earnings +26% on -4% sales revenues in the Mar '12 quarter. Found support near its 200 DMA line during its consolidation since last noted in the 2/21/12 mid-day report - "Extended from prior highs in the $18-19 area and hovering near its 52-week high, stubbornly holding its ground after a recent spurt of gains. The 3 latest quarterly earnings increases (through Dec '11) showed growth above the +25% minimum guideline, satisfying the C criteria. Its annual earnings history included a dip in FY '09."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MA
- NYSE - Finance-CrdtCard/PmtPr
Mastercard Inc Cl A
|
$425.87 |
-15.76
-3.57%
|
$434.98
|
$466.98
|
-8.80% |
592,444
63.77%
|
929,100
|
Most Recent Note for MA - 7/9/2012 12:13:59 PM
Gapped down today following an analyst downgrade, trading near its 50 DMA line. Found support above its 200 DMA line during its consolidation since last noted on 5/18/12 when, based on technical deterioration, it was dropped from the Featured Stocks list.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVO
- NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
|
$146.80 |
-0.01
-0.01%
|
$146.82
|
$152.31
|
-3.62% |
385,944
83.97%
|
459,600
|
Most Recent Note for NVO - 7/9/2012 12:15:07 PM
Rebounded above its 50 DMA line in recent weeks and it is now perched -3.6% off its all-time high. Its 3 latest quarterly comparisons through Mar '12 had earnings increases below the +25% guideline (not meeting the C criteria). It went through a deep consolidation below its 200 DMA line then rebounded since noted in the 7/28/11 mid-day report. - "It has earned high ranks after demonstrating strong steady annual earnings (A criteria) growth. This Denmark-based Medical - Ethical Drug firm also has seen the number of top-rated funds owning its shares rise from 152 in Mar '10 to 204 in Mar '11, a reassuring sign concerning the I criteria."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PATK
- NASDAQ - Bldg-Mobile/Mfg & RV
Patrick Industries Inc
|
$14.74 |
+0.50
3.51%
|
$14.75
|
$14.75
|
-0.07% |
157,027
82.65%
|
190,000
|
Most Recent Note for PATK - 7/9/2012 12:18:14 PM
Touched a new 52-week high with today's 6th consecutive gain, rising from an orderly base with no overhead supply to act as resistance. Reported earnings of 63 cents per share in the quarter ended March 31, 2012 versus a penny in the year ago period. Prior mid-day reports noted - "Fundamentally it is not a match with the fact-based investment system's guidelines. Low-priced stocks are discouraged from consideration as buy candidates unless all key criteria are solidly satisfied."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PCOM
- NASDAQ - Leisure-Services
Points International Ltd
|
$12.04 |
-0.42
-3.37%
|
$12.51
|
$13.07
|
-7.88% |
32,372
69.62%
|
46,500
|
Most Recent Note for PCOM - 7/9/2012 12:20:57 PM
Pulled back near its 50 DMA line earlier today, yet it is well up from the session's early lows. A recent pullback below the 50 DMA line tested a prior resistance level since noted in the 5/04/12 mid-day report - "Reported earnings of 4 cents per share versus a year ago loss of 1 cent per share while sales revenues were -2% for the quarter ended March 31, 2012. Technically, this low-priced stock broke out with volume-driven gains on 4/12/12 and 4/13/12 clearing prior resistance in the $11 area, and no resistance remains due to overhead supply. Strong earnings increases in the Jun, Sep, and Dec '11 quarterly comparisons were above the +25% minimum guideline, satisfying the C criteria. Annual earnings (A criteria) history improved in recent years, but it has not been strong and steady."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
QCOR
- NASDAQ - DRUGS - Biotechnology
Questcor Pharmaceuticals
|
$56.21 |
+5.98
11.91%
|
$58.91
|
$58.91
|
-4.58% |
3,775,341
198.96%
|
1,897,500
|
Most Recent Note for QCOR - 7/9/2012 12:22:34 PM
Hitting a new 52-week high after a considerable gap up and volume-driven gain today, getting more extended from prior highs. It hardly looked back since a considerable volume-driven gain on 6/12/12 helped it break out above previously stubborn resistance in the $46 area. Reported earnings +205% on +161% sales revenues for the quarter ended March 31, 2012 versus the year ago period. Strong prior quarterly comparisons with solid sales revenues and earnings increases satisfy the C criteria of the fact-based system. Downward turn in its FY '09 earnings was previously noted as a flaw concerning the A criteria. Rallied 4-fold from its February 2011 lows in the $12 area.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SAM
- NYSE - FOOD & BEVERAGE - Beverages - Brewers
Boston Beer Company
|
$118.82 |
-5.57
-4.48%
|
$121.95
|
$128.07
|
-7.22% |
148,049
113.80%
|
130,100
|
Most Recent Note for SAM - 7/9/2012 12:25:02 PM
Gapped down today, pulling back from new 52-week highs hit last week. Volume-driven gains had helped it rally into new high territory since last noted in the 6/13/12 mid-day report - "The Dec '11 and Mar '12 quarters showed improved earnings and sales revenues increases after a streak of at least 3 sub-par quarterly comparisons. Its annual earnings (A criteria) showed a downturn in FY '08 followed by strong growth."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
STZ
- NYSE - FOOD & BEVERAGE - Beverages - Wineries & Distill
Constellation Brands A
|
$28.15 |
-0.31
-1.09%
|
$28.60
|
$28.97
|
-2.83% |
1,888,529
59.63%
|
3,166,900
|
Most Recent Note for STZ - 7/9/2012 12:25:52 PM
Holding its ground today following a considerable spurt of volume-driven gains for new 52-week highs. Prior mid-day reports noted - "Quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SYNC
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Application Software
Synacor Inc
|
$17.17 |
+1.72
11.13%
|
$17.49
|
$17.49
|
-1.83% |
832,099
71.90%
|
1,157,300
|
Most Recent Note for SYNC - 7/9/2012 12:29:57 PM
Gapped up and hit another new 52-week high today following a strong finish on the prior session. The 7/06/12 mid-day report noted - "Rallying from a choppy 5-week consolidation above its 50 DMA line. Up from its 2/10/12 IPO at $5.00 and its limited history is a concern."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
USPH
- NYSE - HEALTH SERVICES - Specialized Health Services
U S Physical Therapy
|
$26.38 |
+0.55
2.13%
|
$26.60
|
$26.59
|
-0.79% |
40,408
73.87%
|
54,700
|
Most Recent Note for USPH - 7/9/2012 12:31:30 PM
Touched a new 52-week high today. Last noted in the 5/25/12 mid-day report - "Sales and earnings growth history is not a good match for the investment system's winning models today, as was the case when last noted in the 4/19/11 mid-day report."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
V
- NYSE - Finance-CrdtCard/PmtPr
Visa Inc Cl A
|
$122.19 |
-3.09
-2.47%
|
$123.50
|
$127.47
|
-4.14% |
2,315,349
60.10%
|
3,852,400
|
Most Recent Note for V - 7/9/2012 12:36:05 PM
Gapped down today, slumping toward its 50 DMA line. Last week it wedged to new high territory without great volume conviction. It rebounded through all overhead supply up through the $125 area since last noted on 6/01/12 when, based on technical deterioration and some fundamental concerns, it was dropped from the Featured Stocks list.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MIDDAY BREAKOUTS REPORT - MONDAY, JULY 9TH, 2012
